The programme for the visit included meetings between Latvian companies and representatives of the German business, research, life sciences and healthcare ecosystems. During these meetings, market developments, innovation and potential opportunities for collaboration were discussed.
It should be noted that German companies are currently driving investment projects in Latvia worth more than 600 million euros. In Olpha’s view, the growing economic cooperation between the two countries also opens up new opportunities for Latvian pharmaceutical and life sciences companies that are developing competitive products and wish to expand their operations in Europe.
Photo: Latvian Investment and Development Agency
